Sodium-glucose cotransporter 2 (SGLT-2): Cause of prolonged euglycaemic ketoacidosis and ketonaemia following general anaesthesia?

被引：0
|
作者：
Chong, Z. M. [1 ]
Stirling, A. [1 ]
Sandeep, T. [1 ]
机构：
[1] Monklands Hosp, Diabet & Endocrinol, Airdrie, Lanark, Scotland
来源：
DIABETIC MEDICINE | 2018年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P205
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
    Reid, Jessica
    Rana, Khyatiben
    Niman, Stephanie
    Sheikh-Ali, Mae
    Lewis, Todd
    Choksi, Rushab R.
    Goldfaden, Rebecca F.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 419 - 429
  • [2] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors for Cardiovascular Disease Prevention
    Jessica Reid
    Khyatiben Rana
    Stephanie Niman
    Mae Sheikh-Ali
    Todd Lewis
    Rushab R. Choksi
    Rebecca F. Goldfaden
    American Journal of Cardiovascular Drugs, 2020, 20 : 419 - 429
  • [3] Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad
    Preethika Ekanayake
    Christopher Hupfeld
    Sunder Mudaliar
    Current Diabetes Reports, 2020, 20
  • [4] Sodium-glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class
    da Silva, Paula Nogueira
    da Conceicao, Raissa Alves
    Maia, Rodolfo do Couto
    de Castro Barbosa, Maria Leticia
    MEDCHEMCOMM, 2018, 9 (08) : 1273 - 1281
  • [5] Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad
    Ekanayake, Preethika
    Hupfeld, Christopher
    Mudaliar, Sunder
    CURRENT DIABETES REPORTS, 2020, 20 (12)
  • [6] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes
    Kramer, Caroline K.
    Zinman, Bernard
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 323 - 334
  • [7] Case of sodium-glucose cotransporter-2 inhibitor-associated euglycaemic diabetic ketoacidosis
    Yeoh, Huei Li
    Lee, Marilyn
    Pan, Woei Jack
    Ong, Hean Yee
    BMJ CASE REPORTS, 2021, 14 (08)
  • [8] Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes
    Mende, Christian W.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 541 - 551
  • [9] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors in Heart Failure: An Umbrella Review
    Roy, Raj
    Vinjamuri, Saketh
    Salian, Rishabh Baskara
    Hafeez, Nosheen
    Sundaram, Dakshin Meenashi
    Patel, Tirath
    Gudi, Thulasi Ram
    Vasavada, Advait M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [10] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Benefits in Diabetics With Cardiovascular Disease
    Aftab, Saba
    Suresh, Rishwanth Vetrivel
    Sherali, Nazleen
    Daniyal, Muhammad
    Tsouklidis, Nicholas
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
12345